glp-1 optimization Glucagon-like peptide-1 receptor: mechanisms and advances in therapy 1 support Appetite GLP-1 Optimization Package – Key Benefits 1 in 8 Americans is

Approved GLP-1 RAs: Indications and Administration Dulaglutide (Trulicity) (injection weekly) Type 2 Diabetes Exenatide extended-release (Bydureon bcise) (injection weekly) Type 2 Diabetes Exenatide (Byetta) (injection twice daily) Type 2 Diabetes Semaglutide (Ozempic) (injection weekly) Type 2 Diabetes Liraglutide (Victoza, Saxenda) (injection daily) Obesity and Type 2 Diabetes, Respectively Lixisenatide (Adlyxin) (injection daily) Type 2 Diabetes Semaglutide (Rybelsus) (taken by mouth once daily) Obesity Semaglutide (Wegovy) (injection weekly) Obesity Tirzepatide* (Mounjaro, Zepbound)(injection weekly) Type 2 Diabetes and Obesity, Respectively View the FDAs up-to-date list of approved GLP-1 RAs Cardiovascular Risk Reduction Benefits of GLP-1 RAs for Patients with T2D 2 to 4 times more likely to develop cardiovascular disease (CVD) than those without T2D

Iqubal MK, Md S, Ali J, Baboota S

BPC-157 weight-based dosing

doi.org/10.1046/j.1464-410X.1998.00683.x Salas-Huetos A, Rosique-Esteban N, Becerra-Toms N, et al

If you have any questions about pricing or financing options, please feel free to give our office a call at 303-839-7980 or fill out our contact form